0.61HKD
3.85 BHKD
244.70 BHKD
1.69 B
About CHINA RESOURCES PHARMACEUTICAL GR
Sector
CEO
Xiao Song Bai
Headquarters
Hong Kong
Website
Employees (FY)
72.99 K
Founded
1938
ISIN
HK0000311099
FIGI
BBG00DZWSDQ5
China Resources Pharmaceutical Group Ltd. is an investment holding, which engages in the research and development, manufacture, distribution, and retail of pharmaceutical and healthcare products. It operates through the following segments: Manufacturing, Distribution, Retail, and Others. The Manufacturing segment handles the research and development, manufacture, and sale of pharmaceutical and healthcare products. The Distribution segment focuses on the distribution, warehousing, logistics, and pharmaceutical supply chain solutions and services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. The Retail segment deals with the operation of retailing of pharmacy stores. The Others segment comprises of property holding. The company was founded in 1938 and is headquartered in Hong Kong.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 3320 is 4.65 HKD — it has decreased by 1.06% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CHINA RESOURCES PHARMACEUTICAL GR stocks are traded under the ticker 3320.
CHINA RESOURCES PHARMACEUTICAL GR is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for CHINA RESOURCES PHARMACEUTICAL GR has a max estimate of 9.30 HKD and a min estimate of 4.90 HKD.
3320 earnings for the last quarter are 0.48 HKD whereas the estimation was 0.23 HKD which accounts for 108.98% surprise. Estimated earnings for the next quarter are 0.20 HKD. See more details about CHINA RESOURCES PHARMACEUTICAL GR earnings.
CHINA RESOURCES PHARMACEUTICAL GR revenue for the last quarter amounts to 138.94 B HKD despite the estimated figure of 137.92 B HKD. In the next quarter revenue is expected to reach 137.27 B HKD.
Yes, you can track CHINA RESOURCES PHARMACEUTICAL GR financials in yearly and quarterly reports right on TradingView.
Like other stocks, 3320 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHINA RESOURCES PHARMACEUTICAL GR stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 72.99 K employees. See our rating of the largest employees — is CHINA RESOURCES PHARMACEUTICAL GR on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHINA RESOURCES PHARMACEUTICAL GR EBITDA is 13.70 B HKD, and current EBITDA margin is 5.69%. See more stats in CHINA RESOURCES PHARMACEUTICAL GR financial statements.